Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.18%), DAX30 (0.09%), CAC40 +0.27%

Dec 22 ,2023

  • Synopsis

    • European indices are set to open mixed as Christmas holidays begin with UK and Ireland markets closing early at 12:30GMT.

    • Asian equities are trading mixed. Japan's markets set to close higher to track Wall Street's overnight gains. Australia was flat. Hang Seng lower from earlier gains following new restrictions placed on gaming companies; mainland stocks also lower.

    • US equities ended higher on Thursday, near best levels. Comes after stocks came under notable pressure on Wednesday in a late-day selloff; S&P suffered biggest pullback since September and DJIA and Nasdaq both snapped nine-day winning streaks. Initial jobless claims rose slightly w/w but came in below consensus. Continuing claims largely in line, coming off mid-November's peak levels.

    • In Macro: UK Nov Retail Sales +0.1% y/y vs consensus (1.3%) and prior revised (2.5%) from (2.4%). UK Q3 GDP +0.3% y/y vs preliminary +0.6%. Denmark Nov Retail Sales +6.3% y/y vs consensus +4.0%. Denmark Q3 final GDP (0.7%) q/q vs 2nd estimate (0.1%).

    • Macroeconomic releases due today include: UK Nov car production. France Dec consumer confidence, Nov PPI, Spain Q3 final GDP, Italy Dec business/consumer confidence, Netherlands Q3 final GDP, unemployment rate, retail sales, Belgium Dec CPI, Ireland Nov PPI

    • In corporate news: (ORA.FP) Orange receives offer for Orange bank from Ripplewood -- Le Figaro

  • Politics/Macro/World News

    • The 11 Big Trades of 2023: From Market Busts to Career-Making Wins (Bloomberg)

    • China bans export of rare earths processing tech over national security (Reuters)

    • Strike that disrupted Eurotunnel and Eurostar ends (BBC)

  • Top company news

    • Earnings/updates

      • BHG.SS (BHG Group) -- continues to consolidate and simplify the structure to improve profitability and competitiveness; will reduce cost by SEK 30M on an annual basis in 2024

    • M&A

      • TTE.FP (TotalEnergies) -- signs an agreement with Thailand's national oil and gas company PTTEP for the sale of a 25.5% equity stake in the Seagreen offshore wind farm for a consideration of £522M ($689M)

      • NXI.FP (Nexity) -- enters into exclusive negotiations with Bridgepoint to sell its retail service activities

      • MAU.FP (Maurel et Prom) -- completes the acquisition of Wentworth Resources

      • HSBA.LN (HSBC Holdings) -- Canadian government to approve Royal Bank of Canada's acquisition of HSBC Canada - Bloomberg

      • HSBA.LN (HSBC Holdings) -- Royal Bank of Canada confirms receipt of Canadian government approval to proceed with acquisition of HSBC Canada

      • CRH.LN (CRH plc) -- CRH's Oldcastle APG acquires Waupaca Northwoods' Nampa facility

      • RI.FP (Pernod Ricard) -- to sell the Becherovka brand and related assets to Maspex Group for an undisclosed sum

      • RWE.GR (RWE) -- acquires 4.2-gigawatt UK offshore wind development portfolio from Vattenfall

      • BFIT.NA (Basic-Fit) -- intends to acquire 47 Spanish clubs of RSG Group

      • SHA.GR (Schaeffler) -- expects cost efficiency to become even more important in the coming years amid competition from Chinese EV makers - FT

      • EQT.SS (EQT AB) -- to acquire majority stake in Indium Software; terms undisclosed

      • NAS.NO (Norwegian Air Shuttle) -- receives Norwegian Competition Authority approval to acquire Wideroe

      • 500257.IN (Lupin Ltd) -- enters asset purchase agreement for AARANE, NALCROM with Sanofi for €10M (INR910M) cash

      • DLG.IM (De'Longhi) -- announces business combination between Eversys and La Marzocco

      • EVE.SW (Evolva Holding) -- Shareholders approve sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting; closing is expected to occur on 28-Dec

      • ALSN.SW (ALSO Holding) -- buys three companies in Czech Republic, Slovakia; terms undisclosed

      • EPRO.B.SS (Electrolux Professional) -- to acquire Tosei Corporation for SEK1.65B (¥23.25B)

      • BEIA.B.SS (Beijer Alma) -- Beijer Alma's subsidiary Lesjöfors divests Stumpp & Schüle

      • BSS.IM (Biesse) -- agrees to acquire GMM Group for equity value €72M

      • RAP1V.FH (Rapala VMC) -- completes acquisition of 13 Fishing; purchases remaining shares of DQC international

    • Healthcare

      • AZN.LN (AstraZeneca) -- and Ionis note FDA approval of WAINUA for treatment of ATTRv-PN

      • IONS (Ionis Pharmaceuticals) -- FDA approves Ionis' eplontersen for the treatment of ATTRv-PN -- website

      • 6AP0.GR (Neurogene) -- Neurogene, Inc. SEC filing: SC 13D (Filed by McMinn Rachel)

      • ^HEALTH (Healthcare sector summaries) -- StreetAccount Sector Summary - Healthcare Post-Market

      • POXEL.FP (Poxel) -- focused on securing additional financing; entered into a new cost-saving plan

      • MITRA.BB (Mithra Pharmaceuticals) -- and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA in Israel

      • SFL.IM (Safilo Group) -- communicates the interruption of the licensing agreement with the CHIARA FERRAGNI brand

    • Other

      • DBK.GR (Deutsche Bank) -- discovers thousands of unresolved complaints in Postbank - FT

      • ELUX.B.SS (Electrolux) -- CORRECTION: Electrolux Professional to acquire Tosei Corporation for SEK1.65B (¥23.25B)

      • BA.LN (BAE Systems) -- awarded $86.8M U.S. NAVY IDIQ contract

      • DG.FP (VINCI SA) -- VINCI implements share buyback program within the limit of €600M

      • BAER.SW (Julius Baer Group) -- Follow-up: FINMA investigating Julius Baer over risk lapses related to Signa insolvency - Bloomberg

      • LXS.GR (Lanxess) -- CORRECTION: Lanxess downgraded to hold from buy at Alster Research (intra-day 21-Dec

      • NEOEN.FP (Neoen) -- signs contract in NSW and launches construction of 440 MWp Culcairn Solar Farm in Australia

      • MOL.HB (MOL Hungarian Oil & Gas) -- reports first gas reached in Rozhkovskoye field, Kazakhstan

      • UK November car manufacturing +14.8% y/y to 91,923 units - SMMT

  • Key rating changes

    • Downgrades

      • LXS.GR (Lanxess) -- to hold from buy at Alster Research (intra-day 21-Dec)

      • PFC.LN (Petrofac) -- Petrofac reinstated hold at Peel Hunt; prior rating was buy

      • NOLA.B.SS (Nolato) -- to hold from buy at SEB

  • Data

    • Nikkei +0.09% to 33169.05

    • Hang Seng (1.68%) to 16342.68

    • Shanghai Composite (0.17%) to 2913.82

    • S&P futures (7.5) vs prior close of 4796.8

    • €-$ (0.0011) or (0.10%) to 1.1001

    • $-¥ +0.19 or +0.14% to 142.31

    • €-¥ +0.03 or +0.02% to 156.51

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE